查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1546239

全球輻射劑量管理市場

Radiation Dose Management
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球輻射劑量管理市場預計將達到 8.352 億美元

全球輻射劑量管理市場預計 2023 年為 3.411 億美元，預計到 2030 年將達到 8.352 億美元，2023-2030 年分析期間複合年成長率為 13.6%。輻射劑量管理解決方案是本報告分析的細分市場之一，預計複合年成長率為 14.0%，到分析期結束時將達到 4.796 億美元。分析期間輻射劑量管理服務業的複合年成長率預計為 13.2%。

美國市場預計9,200萬美元，中國預計複合年成長率12.7%

預計2023年美國輻射劑量控制市場規模將達9,200萬美元。中國作為世界第二大經濟體，預計2030年市場規模將達到1.263億美元，2023-2030年分析期間複合年成長率為12.7%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間複合年成長率分別為 12.3% 和 11.3%。在歐洲，德國的複合年成長率預計約為 9.8%。

全球輻射劑量管理市場 - 主要趨勢和促進因素總結

輻射劑量管理：確保醫學影像診斷中的病人安全

輻射劑量管理是指在 X 光、 電腦斷層掃描和核子醫學等醫學影像處理過程中監測、管理和最佳化病患輻射暴露的系統方法。此過程對於確保患者安全同時實現準確醫療評估所需的診斷品質至關重要。過度的輻射暴露會增加癌症等不良健康影響的風險，因此必須在保持診斷資訊完整性的同時最大限度地減少輻射暴露。輻射劑量管理系統旨在追蹤輻射劑量，提醒醫療保健專業人員潛在的過度暴露，並實施最佳實踐來最佳化輻射使用。隨著診斷成像的使用在全球範圍內不斷增加，此類系統的實施變得越來越重要。

技術進步如何改善輻射劑量控制？

技術進步顯著改善了輻射劑量管理系統，使其更有效率、準確，並整合到醫療保健工作流程中。最新的系統結合了先進的分析和機器學習演算法，可以即時分析輻射劑量資料，向醫療保健提供者提供即時回饋。這些系統可以根據患者體型、年齡和特定診斷要求自動調整成像通訊協定，在不影響影像品質的情況下最大限度地減少不必要的輻射暴露。透過整合輻射劑量管理系統和電子健康記錄(EHR)，可以無縫記錄和追蹤患者的輻射歷史，從而實現對未來診斷成像的更個人化和明智的決策。此外，劑量最佳化軟體的進步使得不同成像設備之間的通訊協定標準化成為可能，從而確保整個醫療機構輻射管理的一致性。這些技術進步正在促進先進輻射劑量管理系統的實施，提高病人安全並改善醫學影像結果。

輻射劑量管理在醫學影像診斷的主要用途和好處是什麼？

輻射劑量管理系統用於各種診斷成像模式，並具有許多好處，可以提高患者安全性、遵守監管標準以及醫療保健的整體品質。在診斷放射學中，它有助於監測和減少電腦斷層掃描，眾所周知，與其他影像技術相比，CT 掃描的輻射劑量相對較高。在介入放射學中，通常需要長時間暴露，而輻射劑量控制對於保護患者和醫護人員免受過度輻射至關重要。輻射劑量控制在兒科影像診斷中也很有效，其中最大限度地減少輻射暴露尤其重要，因為兒童對輻射高度敏感。此外，輻射劑量管理系統支援遵守核能(IAEA) 和歐洲核能共同體 (Euratom) 等國際標準和法規，確保醫療保健提供者滿足安全要求。輻射劑量管理的主要好處包括提高病人安全性、改善臨床決策以及降低輻射引起的併發症的風險，使其成為現代醫學影像的重要組成部分。

推動輻射劑量管理市場成長的因素有哪些？

輻射劑量管理市場的成長受到多種因素的推動。醫療保健專業人員和患者對輻射安全的認知不斷提高，這主要是由於關注盡量減少醫學影像期間的輻射暴露。劑量管理軟體、資料分析和機器學習等技術進步也透過提高這些系統的準確性和效率來推動市場成長。全球範圍內診斷成像程序數量的不斷增加，特別是在老齡化社會中，進一步推動了對輻射劑量管理解決方案的需求。此外，有關輻射安全的嚴格監管要求和認證標準也促進了市場的成長。醫療保健提供者正在嘗試透過實施先進的劑量管理系統來遵守這些法規。此外，電子健康記錄(EHR) 的日益普及以及劑量管理系統與 EHR 的整合也支持了市場擴張。這些因素加上醫療保健技術的持續創新，正在推動輻射劑量管理市場的持續成長。

調查企業舉例（共11家）

  • Agfa HealthCare
  • Bayer AG
  • Bracco Imaging SpA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Medsquare
  • Novarad Corporation
  • PACSHealth LLC
  • Philips Healthcare
  • Qaelum NV
  • Sectra AB
  • Siemens Healthineers

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP14319

Global Radiation Dose Management Market to Reach US$835.2 Million by 2030

The global market for Radiation Dose Management estimated at US$341.1 Million in the year 2023, is expected to reach US$835.2 Million by 2030, growing at a CAGR of 13.6% over the analysis period 2023-2030. Radiation Dose Management Solutions, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$479.6 Million by the end of the analysis period. Growth in the Radiation Dose Management Services segment is estimated at 13.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$92.0 Million While China is Forecast to Grow at 12.7% CAGR

The Radiation Dose Management market in the U.S. is estimated at US$92.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$126.3 Million by the year 2030 trailing a CAGR of 12.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.3% and 11.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.

Global Radiation Dose Management Market - Key Trends and Drivers Summarized

Radiation Dose Management: Ensuring Patient Safety in Medical Imaging

Radiation dose management refers to the systematic approach to monitoring, controlling, and optimizing the amount of radiation exposure patients receive during medical imaging procedures such as X-rays, CT scans, and nuclear medicine. This process is crucial in ensuring patient safety while achieving the diagnostic quality necessary for accurate medical evaluations. Excessive radiation exposure can increase the risk of adverse health effects, including cancer, making it essential to minimize exposure while maintaining the integrity of the diagnostic information. Radiation dose management systems are designed to track radiation doses, alert healthcare providers to potentially excessive exposure levels, and implement best practices to optimize radiation use. The implementation of these systems is becoming increasingly important as the use of diagnostic imaging continues to grow worldwide.

How Are Technological Advancements Enhancing Radiation Dose Management?

Technological advancements have significantly improved radiation dose management systems, making them more efficient, precise, and integrated into healthcare workflows. Modern systems now incorporate advanced analytics and machine learning algorithms that analyze radiation dose data in real-time, providing immediate feedback to healthcare providers. These systems can automatically adjust imaging protocols based on patient size, age, and the specific diagnostic requirement, thereby minimizing unnecessary exposure without compromising image quality. The integration of radiation dose management systems with electronic health records (EHRs) allows for seamless documentation and tracking of patient radiation histories, enabling more personalized and informed decisions about future imaging procedures. Additionally, advancements in dose optimization software have made it possible to standardize protocols across different imaging devices, ensuring consistency in radiation management across a healthcare facility. These technological improvements are driving the adoption of sophisticated radiation dose management systems, enhancing patient safety and improving outcomes in medical imaging.

What Are the Key Applications and Benefits of Radiation Dose Management in Medical Imaging?

Radiation dose management systems are utilized across various imaging modalities, offering numerous benefits that enhance patient safety, compliance with regulatory standards, and overall healthcare quality. In diagnostic radiology, these systems help monitor and reduce radiation exposure during CT scans, which are known for their relatively high radiation doses compared to other imaging techniques. In interventional radiology, where procedures often involve prolonged exposure times, radiation dose management is critical for protecting both patients and healthcare staff from excessive radiation. The systems are also valuable in pediatric imaging, where minimizing radiation exposure is particularly important due to the increased sensitivity of children to radiation. Furthermore, radiation dose management systems support compliance with international standards and regulations, such as those set by the International Atomic Energy Agency (IAEA) and the European Atomic Energy Community (Euratom), ensuring that healthcare providers meet safety requirements. The primary benefits of radiation dose management include enhanced patient safety, improved clinical decision-making, and reduced risk of radiation-induced complications, making it an essential component of modern medical imaging practices.

What Factors Are Driving the Growth in the Radiation Dose Management Market?

The growth in the Radiation Dose Management market is driven by several factors. The increasing awareness of radiation safety among healthcare providers and patients is a significant driver, as more emphasis is placed on minimizing radiation exposure during medical imaging. Technological advancements in dose management software, data analytics, and machine learning are also propelling market growth by improving the precision and efficiency of these systems. The rising number of diagnostic imaging procedures worldwide, particularly in aging populations, is further boosting demand for radiation dose management solutions, as these systems are essential for ensuring patient safety in high-volume imaging environments. Additionally, stringent regulatory requirements and accreditation standards related to radiation safety are contributing to market growth, as healthcare providers seek to comply with these regulations by implementing advanced dose management systems. The growing adoption of electronic health records (EHRs) and the integration of dose management systems with EHRs are also supporting market expansion, as these technologies enable better tracking and optimization of radiation exposure. These factors, combined with continuous innovation in healthcare technology, are driving the sustained growth of the Radiation Dose Management market.

Select Competitors (Total 11 Featured) -

  • Agfa HealthCare
  • Bayer AG
  • Bracco Imaging SpA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Medsquare
  • Novarad Corporation
  • PACSHealth LLC
  • Philips Healthcare
  • Qaelum N.V.
  • Sectra AB
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Radiation Dose Management - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Patient Safety and Radiation Protection Propels Market Growth
    • Technological Advancements in Dose Tracking and Monitoring Software Strengthen Market Position
    • Growing Adoption of Digital Health Records Drives Integration of Dose Management Systems
    • Surge in Demand for Dose Management Solutions in Diagnostic Imaging Generates New Opportunities
    • Development of AI and Machine Learning-Based Dose Optimization Sustains Market Growth
    • Expanding Applications in Interventional Radiology Throws Spotlight on Market Potential
    • Growth in Radiology Practices and Imaging Centers Spurs Demand for Dose Management
    • Increasing Awareness of Radiation-Induced Health Risks Strengthens Business Case
    • Rising Adoption of Cloud-Based Dose Management Solutions Propels Market Expansion
    • Surge in Demand for Automated Dose Monitoring in Radiation Therapy Expands Market Horizons
    • Growing Emphasis on Compliance with International Radiation Safety Standards Drives Market Adoption
    • Innovations in Real-Time Dose Monitoring and Reporting Generate New Market Opportunities
    • Rising Demand for Dose Management in Pediatric and Geriatric Imaging Throws Spotlight on Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World 7-Year Perspective for Computed Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Radiography & Mammography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 4: World 7-Year Perspective for Radiography & Mammography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Nuclear Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World 7-Year Perspective for Nuclear Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Ambulatory Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 10: World 7-Year Perspective for Ambulatory Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 11: World Radiation Dose Management Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Radiation Dose Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Radiation Dose Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Fluoroscopy & Interventional Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Fluoroscopy & Interventional Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: USA 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Canada 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Canada 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • JAPAN
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Japan 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Japan 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • CHINA
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: China 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: China 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • EUROPE
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Europe 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Europe 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe 7-Year Perspective for Radiation Dose Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Europe 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • FRANCE
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: France 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: France 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • GERMANY
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Germany 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Germany 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Italy 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 71: Italy 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • UNITED KINGDOM
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 73: UK 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 77: UK 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Rest of World 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 95: Rest of World 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030

IV. COMPETITION